Carlos Rodriguez-Galindo MD

Pediatric Hematology & Oncology•Memphis, TN

Associate Professor of Pediatrics, Boston Children's Hospital

262 Danny Thomas PlMemphis, TN 38105
Phone+1 901-595-3300
Fax+1 617-632-5710

Dr. Rodriguez-Galindo is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rodriguez-Galindo's full profile Already have an account?

Education & Training

Universidad de Barcelona Faculty of MedicineClass of 1986

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TN State Medical License 2008 - 2028
MA State Medical License 2009 - 2016
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2014

Clinical Trials

Carboplatin Plus Vincristine in Treating Children With Retinoblastoma
COMPLETED
PHASE2
Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma
COMPLETED
PHASE2
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
UNKNOWN
PHASE3

Publications & Presentations

PubMed

Navigating the Planning and Initiation of a First Prospective Clinical Trial Through a Regional Pediatric Oncology Consortium Within the Middle East, Africa, and Asia-...
Ruzanna Papyan, Farah Ghamloush, Iman Sidhom, Asim Belgaumi, Rihab Nasr
Pediatric Blood & Cancer. 2026-07-31
Clofarabine for relapsed/refractory LCH and non-LC histiocytosis.
Barbara A Degar, Oussama Abla, Patrick K Campbell, Alison M Friedmann, Michael M Henry
Blood Advances. 2026-07-28
Disease extent, not lesion location, determines relapse risk in single-system skeletal Langerhans cell histiocytosis.
Itziar Astigarraga, Helga Arnardottir, Oussama Abla, Maurizio Arico, Jorge Braier
Blood Advances. 2026-07-14

Press Mentions

St. Jude Redesignation Marks Collaboration with WHO Toward Improved Pediatric Cancer Outcomes GloballyJune 18th, 2026
Tennessee Hospital Welcomes First Ukraine Child Cancer PatientsMarch 23rd, 2022
Genetic Ancestry Provides Important Context for Understanding Global Diversity in Childhood LeukemiaJanuary 27th, 2022

Grant Support

Defining Clinical Research Priorities and Strengthening Diversity and Patient-Stakeholder Engagement in Histiocytic DisordersST. JUDE CHILDREN'S RESEARCH HOSPITAL2024